[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

USCorpFilings Avatar SEC Filings Digest @USCorpFilings on x 4419 followers Created: 2025-07-25 13:30:08 UTC

$KRYS New Product Launches:

On July 25, 2025, Krystal Biotech, Inc. announced that Japan's Ministry of Health approved its product VYJUVEKĀ® for treating Dystrophic Epidermolysis Bullosa.

XXX engagements

Engagements Line Chart

Related Topics approved $krys

Post Link